{"pdfurl": "http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/1996/06/27/090224b0828cd381/_/Rendered/PDF/multi0page.pdf", "lang": "English", "historic_topic": "Health, Nutrition and Population", "volnb": "1", "display_title": [{"display_title": "China - Pharmaceuticals Project"}], "repnb": "15831", "docna": {"cdata!": "China - Pharmaceuticals Project"}, "repnme": {"cdata!": "China - Pharmaceuticals Project"}, "owner": "China & Mongolia HQ Unit (EACCQ)", "publishtoextweb_dt": "2010-07-01T00:00:00Z", "subtopic": "Environmental Economics & Policies,Pharmaceuticals Industry,Business in Development,Pharmaceuticals & Pharmacoeconomics,Business Environment", "docty": "Implementation Completion and Results Report", "txturl": "http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/1996/06/27/090224b0828cd381/_/Rendered/INDEX/multi0page.txt", "listing_relative_url": "/projects/documents/1996/06/733439/china-pharmaceuticals-project", "teratopic": "Health, Nutrition and Population", "new_url": "1996/06/733439/china-pharmaceuticals-project", "entityids": {"entityid": "000009265_3961214172815"}, "disclosure_type_date": "2010-07-01T00:00:00Z", "disclosure_type": "NA", "docm_id": "090224b0828cd381", "projn": "CN-Industry - Pharmaceu -- P003517", "keywd": {"1": {"cdata!": "accounting,acquisition,auditing,audits,bidding,Chemical\n            Industries,construction contractors,cost\n            estimates,debt,depreciation,deregulation,Drug\n            Administration,drugs,feasibility,financial\n            resources,GMP,Good Manufacturing\n            Practices,Income,inflation,interest\n            rates,management,marketing,marketing,Medicines,Pharmaceutical\n            Administration,pharmaceutical industry,pharmaceutical\n            plants,pharmaceutical production,pharmaceutical\n            products,Pharmaceutical Quality,Pharmaceutical Quality\n            Control,pharmaceutical quality standards,Pharmaceutical\n            Sector,Pharmaceuticals,Procurement,productivity,PROJECT\n            IMPLEMENTATION,Public Health,quality assurance,regulatory authorities,sales,tablets,Tendering"}, "0": {"cdata!": "accounting,acquisition,auditing,audits,bidding,Chemical\n            Industries,construction contractors,cost\n            estimates,debt,depreciation,deregulation,Drug\n            Administration,drugs,feasibility,financial\n            resources,GMP,Good Manufacturing\n            Practices,Income,inflation,interest\n            rates,management,marketing,marketing,Medicines,Pharmaceutical\n            Administration,pharmaceutical industry,pharmaceutical\n            plants,pharmaceutical production,pharmaceutical\n            products,Pharmaceutical Quality,Pharmaceutical Quality\n            Control,pharmaceutical quality standards,Pharmaceutical\n            Sector,Pharmaceuticals,Procurement,productivity,PROJECT\n            IMPLEMENTATION,Public Health,quality assurance,regulatory authorities,sales,tablets,Tendering"}}, "url_friendly_title": "http://documents.worldbank.org/curated/en/1996/06/733439/china-pharmaceuticals-project", "datestored": "2001-04-21T00:00:00Z", "admreg": "East Asia and Pacific,East Asia and Pacific", "geo_region_mdks": {"1": {"geo_region_mdk": "Asia!$!80451"}, "0": {"geo_region_mdk": "Asia!$!80451"}, "2": {"geo_region_mdk": "Asia!$!80451"}}, "majdocty": "Project Documents", "available_in": "English", "disclstat": "Disclosed", "chronical_docm_id": "090224b0828cd381", "totvolnb": "1", "geo_regions": {"1": {"geo_region": "Asia"}, "0": {"geo_region": "Asia"}, "2": {"geo_region": "Asia"}}, "seccl": "Public", "versiontyp_key": "1309935", "subsc": "(Historic)Fertilizer and other chemicals", "count": "China", "sectr": "(Historic)Industry", "disclosure_date": "2010-06-18T00:00:00Z", "url": "http://documents.worldbank.org/curated/en/1996/06/733439/china-pharmaceuticals-project", "versiontyp": "Final", "loan_no": "2943", "abstracts": {"cdata!": "This is the Implementation Completion\n            Report (ICR) for the Pharmaceuticals<BR>Project in\n            China. The objectives of the project were to: 1) Expand\n            pharmaceutical production; 2) Improve the quality of\n            pharmaceutical products; and 3) Improve the quality of\n            training, maintenance, marketing and management in the\n            pharmaceutical industry. All of the Project objectives were\n            met. Overall, the Project is judged to be sustainable.\n            Overall, there was a very strong commitment of the borrower\n            and the project entities at all levels to meet the Project\n            Objectives. The key lessons learned from the project were\n            that experience from the Project again demonstrated the\n            value of careful preparation and that the early involvement\n            of local consultants in assisting in the preparation\n            demonstrated that country specific factors are adequately addressed."}, "docdt": "1996-06-27T00:00:00Z"}